Cannabis Law Report

MAY 29, 2022

In 2017, FDA granted a request for Breakthrough Therapy designation for MDMA to treat PTSD. As previously mentioned, clinical studies are promising, including a Phase 3 trial (the last step before submitting an NDA) completed last November. [9] Clinical Trials and Human Subject Protections. 811(b)–(c). [18]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Freedom Leaf

JULY 20, 2017

Researchers noted that, for many factors, the data showed “an initial decrease in values but [then an] eventual increase.” Several other observational trials have similarly reported that those with a cannabis use history possess lower BMI , and are less likely to be obese or suffer from adult onset diabetes as compared to non-users.

Blood Pressure 43

Blood Pressure Research and Development Clinical Trials History 43

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Weedistry

JANUARY 28, 2019

Cannabinoid-derived product by Ontario-based Tetra Bio-Pharma to be officially recognized as a drug. The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. “The Can medical cannabis be the solution?

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. million dollar grant from the National Institute on Drug Abuse in 2017 to conduct a 5-year study on the effects of cannabis on HIV. 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Weedistry

MARCH 11, 2019

There are studies, she said, showing that for pain relief, CBD works best within the plant’s cannabinoid system, meaning that combinations of compounds are more effective than isolated ones. There is a lot less CBD and other cannabinoids in hemp than in cannabis strains that contain THC. von Pfetten said. von Pfetten said.

Oil 40

Oil CBD Wellness and Beauty Clinical Trials 40

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. million more on CBD products in 2021 compared to 2017 — a 413.4%

CBD 144

CBD Seed-To-Sale Food Access 144

The Joint Blog

FEBRUARY 18, 2020

According to NORML, they reported that the use of medical cannabis, and in particular products dominant in the cannabinoid CBN (cannabinol), was associated with medication-sparing effects. The study is titled Cannabinoid and terpenoid doses are associated with adult ADHD status of medical cannabis patients.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). 2018 ; Månsson 2016 , 2017 ; Abalo 2019a , 2019b ; Paimre 2017 ).

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 17, 2019

THC is just one of the cannabinoids in the Cannabis sativa L. The other major cannabinoid of particular interest commercially is cannabidiol (CBD). Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017.

Law 40

Law Seed-To-Sale Hemp Recreational 40